Alankit approves 10 crore fully convertible warrants at AGM
- Shareholders approved issuance of 10,00,00,000 fully convertible warrants to promoters and public
- Standalone and consolidated financial statements for FY26 were adopted
- Ms. Meera Lal was re-appointed as a director following retirement by rotation
- Multiple related party transactions across subsidiaries were approved

*this image is generated using AI for illustrative purposes only.
Alankit shareholders approved the issuance of up to 10,00,00,000 fully convertible warrants to promoter and public category entities at its 37th Annual General Meeting held on September 8, 2026.
The meeting, which commenced at 11:12 am and concluded at 11:44 am, also saw the adoption of standalone and consolidated audited financial statements for FY26. Members re-appointed Ms. Meera Lal as a director by rotation.
Corporate Actions
The special business agenda included approvals for related party transactions across several subsidiaries and group companies. The board sought consent for dealings with Alankit Assignments Limited, Verasys Limited, Alankit Finsec Limited, Alankit Foundation, and Alankit Wealth Management Private Limited.
Subsidiaries including Alankit Forex India Limited, Alankit Technologies Limited, Alankit Imaginations Limited, Alankit Insurance Brokers Limited, and Verasys Limited received approval for specific related party engagements. These transactions involve interactions with entities such as Pratishtha Images Private Limited and Infosafe Technologies Private Limited.
Director Re-appointment
Ms. Meera Lal, an M.A. in Economics and Professor at St. Xavier's College, Ranchi University, was re-appointed after retiring by rotation. She has served on the board since February 12, 2020, and attended five board meetings during FY25-26. Her remuneration will comprise sitting fees and/or commission on net profits as approved by the board.
Historical Stock Returns for Alankit
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.08% | -1.24% | -1.11% | +0.50% | -42.77% | -47.78% |
How might the issuance of 10 crore fully convertible warrants impact existing shareholder equity and potential dilution in the short to medium term?
What strategic rationale drives the extensive related party transactions with subsidiaries like Alankit Finsec and Verasys, and how will they affect consolidated profitability?
Given the approval of FY26 audited financial statements, what key performance indicators suggest Alankit's resilience or growth trajectory in the current market environment?


































